Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia

Table 3

Comparison of UA and renal function indexes between the two groups before and after treatment (±S).

Group	N		BUN (mmol/L)	Scr (mmol/L)	Na (mmol/L)	K (mmol/L)	UA (μmol/L)
Control group	50	Before treatment	17.24 ± 5.05	326.32 ± 56.24	127.21 ± 12.47	3.36 ± 0.92	503.64 ± 50.31
		After treatment	12.44 ± 5.15^a	275.15 ± 41.62^a	130.35 ± 11.42	3.41 ± 7.39	446.35 ± 42.35^a
Experimental group	50	Before treatment	18.32 ± 4.24	326.23 ± 57.52	128.75 ± 11.24	3.38 ± 1.23	498.36 ± 50.25
		After treatment	10.24 ± 4.11^ab	243.25 ± 41.25^ab	131.24 ± 15.67	3.14 ± 0.32	361.58 ± 28.67^ab

Note. Compared with before treatment, ^a; compared with the control group after treatment, ^b.